Medication Fact Sheets
|
December 19, 2024

Dicyclomine (Bentyl): Uses, Side Effects, and Dosage Guide

Written By
Dr. Jaime Cloyd ND
Medically Reviewed by
Updated On
January 5, 2025

Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits (constipation, diarrhea, or both) without any identifiable structural or biochemical abnormalities. It affects approximately 10-15% of the global population, with a higher prevalence in women and individuals younger than 50.

There is no cure for IBS, so treatment goals continue to focus on symptom management and improving quality of life. According to the American College of Gastroenterology, dicyclomine is an antispasmodic medication that can help treat abdominal pain and cramping associated with IBS.

[signup]

What Is Dicyclomine (Bentyl)?

Dicyclomine, sold under the brand name Bentyl, was approved by the U.S. Food and Drug Administration (FDA) in 1950 for treating functional bowel/irritable bowel syndrome. It is an antispasmodic agent used to treat muscle spasms and pain in the gastrointestinal (GI) tract.  

Dicyclomine is available in 10 mg capsules, 20 mg tablets, an oral syrup, and an injectable solution. 

How Dicyclomine Works

Dicyclomine is classified as an anticholinergic agent, specifically an antimuscarinic. This means that it blocks the actions of acetylcholine. 

Acetylcholine is a neurotransmitter that binds to muscarinic receptors to signal muscles to contract. 

Dicyclomine blocks these muscarinic receptors. You can think of it as placing a cover over the lock so that acetylcholine can't attach and send its contraction signal. In doing so, it facilitates muscular relaxation.  

Additionally, dicyclomine helps reduce muscle spasms by having direct antispasmodic effects on the smooth muscles in the intestines. It blocks chemicals called bradykinin and histamine, which can cause the intestinal muscles to tighten and spasm.  

Dicyclomine is well-absorbed orally, with peak plasma concentrations reached within 60-90 minutes. The injectable form is twice as bioavailable as the oral forms. Patients typically begin to feel relief from symptoms within one hour of taking dicyclomine, and its effects can last for four to six hours.  

Dicyclomine is predominantly eliminated from the body through the kidneys. Its half-life is approximately two hours, which means it stays active in your body for a relatively short period after a single dose. Dicyclomine needs to be taken multiple times throughout the day to maintain its effects.  

Who Should Take Dicyclomine?

Dicyclomine is suitable for patients seeking relief from chronic abdominal pain, particularly that associated with IBS.

According to a study conducted in 1981, patients with IBS who took 40 mg of dicyclomine four times daily had greater improvements in their symptoms, including abdominal pain, tenderness, and bowel function, than those given a placebo. 

Dicyclomine may be suitable for patients seeking relief from chronic abdominal pain associated with IBS, but treatment should be individualized based on patient-specific factors and in consultation with a healthcare provider.

Contraindications

Dicyclomine is contraindicated in individuals with specific medical conditions to prevent adverse effects and ensure patient safety:

Special Populations

Pregnancy: Dicyclomine is a Category B pregnancy drug. This means that animal studies have not shown any risk to the developing fetus, but there is insufficient clinical data in humans. Therefore, dicyclomine should only be used during pregnancy if clearly needed and if the potential benefits outweigh any possible risks.  

Older Patients: Dicyclomine is listed in the Beers Criteria as potentially inappropriate for older adults due to increased sensitivity to anticholinergic effects. It should generally be avoided or used cautiously in geriatric patients to minimize the risk of adverse side effects.  

Renal and Hepatic Impairment: Dicyclomine should be administered cautiously in patients with known kidney and liver dysfunction. 

Dicyclomine Dosage and Administration

The recommended starting dose is 20 mg by mouth four times daily. 

After one week of treatment, your doctor may recommend increasing the dose to 40 mg four times daily. Dosage adjustments should be performed by a qualified healthcare provider based on individual patient needs and medical history. 

Dicyclomine is also available as an injection administered into the muscle at 10-20 mg four times daily for people who can't take the medication by mouth. The injectable solution should not be used for longer than two days and should never be administered into the vein. 

Potential Side Effects of Dicyclomine

Dicyclomine's anticholinergic effects can cause unwanted side effects in more than 5% of people who take it. The most common side effects include: 

  • Dizziness (40%)
  • Dry mouth (33%)
  • Blurred vision (27%)
  • Nausea (14%)
  • Drowsiness (9%)
  • Weakness (7%)
  • Nervousness (6%)
  • Constipation

Tips for Managing Minor Side Effects

  • Drinking plenty of water and chewing sugar-free gum can help alleviate dry mouth.
  • Gradually moving from sitting or lying positions can reduce dizziness.
  • Lubricating eye drops or artificial tears may help with dry eyes and blurred vision.
  • Taking dicyclomine with food can lessen feelings of nausea.
  • Incorporating more fiber into your diet, staying hydrated, and engaging in regular exercise can help manage constipation

Consult your healthcare provider for personalized strategies to manage side effects.

Rare but serious side effects of dicyclomine can occur. These symptoms are more likely to occur in older adults or patients taking medications that can interact with dicyclomine. Symptoms that warrant immediate medical attention include: 

  • Shortness of breath
  • Arrhythmias (irregular heartbeat) 
  • Heart palpitations
  • Confusion
  • Hallucinations
  • Trouble swallowing or talking
  • Heat stroke 
  • Anticholinergic toxicity

Anticholinergic toxicity occurs when there is excessive inhibition of acetylcholine in the nervous system. The following mnemonic is helpful for remembering the classic signs and symptoms it typically presents with:

  • Red as a beet (flushed skin)
  • Dry as a bone (dry mouth and eyes) 
  • Blind as a bat (dilated pupils, blurred vision)
  • Mad as a hatter (confusion, delirium) 
  • Hot as a hare (fever) 
  • Full as a flask (urinary retention)

Interactions With Other Medications

Some medications should not be taken with dicyclomine because they can reduce its effectiveness or increase the risk of adverse effects. Important interactions include: 

  • Glaucoma Medications: Anticholinergics antagonize the effects of antiglaucoma drugs and can increase intraocular pressure. 
  • Antacids: Antacids reduce stomach acid to manage heartburn and indigestion. They can interfere with the absorption of dicyclomine, making it less effective.
  • Other Anticholinergics: Other anticholinergic agents amplify dicyclomine's effects, increasing the risk of serious side effects. Examples of anticholinergic medications include oxybutynin, scopolamine, tricyclic antidepressants, and diphenhydramine. Examples of anticholinergic herbs include Atropa belladonna (belladonna), Datura stramonium (jimsonweed), and Hyoscyamus niger (black henbane).

This is not a complete list of potential interactions. To prevent unwanted drug interactions, always inform your healthcare provider of all medications, supplements, and herbs you are taking before starting dicyclomine.

Not only can alcohol exacerbate IBS symptoms, but it also impairs cognitive function and can intensify some of dicyclomine's side effects, like drowsiness and dizziness. It's recommended to avoid drinking alcohol while taking dicyclomine.

Alternatives to Dicyclomine (Bentyl)

If dicyclomine is not suitable due to intolerable side effects, continued or worsening symptoms, or contraindications, discuss with your healthcare provider the best management strategies for your IBS. 

Alternative treatment options may include:

  • Other Medications: The FDA has approved alosetron, eluxadoline, rifaximin, lubiprostone, and linaclotide for treating IBS.
  • Diet: FODMAPs, which stands for "Fermentable Oligo-, Di-, Mono-saccharides And Polyols," are a group of specific types of carbohydrates that can be difficult for some people to digest. Research suggests that following a low-FODMAP diet can reduce IBS symptoms. 
  • Peppermint Oil: The American College of Gastroenterology recommends giving enteric-coated peppermint oil to patients with IBS based on high-quality evidence suggesting this intervention can significantly improve pain scores. 
  • Stress Reduction: Stress is a common IBS trigger because it can disrupt GI function, leading to increased pain sensitivity and altered bowel function. Cognitive behavioral therapy, mindfulness, and hypnotherapy are examples of evidence-based psychotherapies that can help provide patients with tools to cope with excessive stress to manage and prevent their IBS symptoms.
  • Regular Exercise: Exercise supports GI and mental health. Research indicates that patients with IBS who increase their physical activity experience improved GI and psychological symptoms associated with IBS. 

These alternatives offer various approaches to managing IBS and can be tailored to individual patient needs. Always consult your healthcare provider to determine the most appropriate treatment options for your condition.

Frequently Asked Questions (FAQs) About Dicyclomine (Bentyl)

1. Is Dicyclomine Safe During Pregnancy?

The safety of dicyclomine during pregnancy has not been fully established. Pregnant individuals should consult their healthcare provider to weigh the benefits and risks before using this medication. 

2. How Quickly Does Dicyclomine Work?

Dicyclomine typically begins to relieve symptoms within one hour after ingestion. Its peak effect is usually seen within 2 hours, providing timely relief from GI spasms and discomfort. 

3. Can I Take Dicyclomine Long-Term?

Intramuscular dicyclomine should not be used for longer than two days

Oral dicyclomine may be appropriate for managing IBS long-term; however, safety data are not available for doses above 80 mg daily for longer than two weeks. Prolonged use can increase the risk of side effects, especially in elderly patients. Patients taking dicyclomine long-term should follow up with their healthcare provider regularly to monitor the drug's effectiveness and safety. 

4. Does Dicyclomine Affect Mental Health?

Dicyclomine can affect the central nervous system, potentially affecting mood and cognitive function. These side effects are more likely to occur in patients older than 65 or those with preexisting mental health conditions. If you experience changes in mood or cognitive function while taking dicyclomine, consult your healthcare provider promptly.  

[signup]

Key Takeaways

  • Dicyclomine (Bentyl) is an FDA-approved medication for treating IBS.
  • Its antispasmodic properties effectively reduce abdominal pain and cramping, enhancing the quality of life for many patients. 
  • However, like all medications, it carries potential side effects and interactions that necessitate careful consideration and consultation with healthcare providers.
  • If you are struggling with IBS or related GI issues, consult your healthcare provider to determine if dicyclomine is the right treatment option for you.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. Adelman, M. (2024, February 9). Acid Reducers and Nutrient Absorption: What You Need to Know. Rupa Health. https://www.rupahealth.com/post/acid-reducers-and-nutrient-absorption-what-you-need-to-know
  2. AGS AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults Guideline Summary. (2023, May 4). Guideline Central. https://www.guidelinecentral.com/guideline/340784/
  3. Bentyl (dicyclomine hydrochloride) capsules label. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/007409s041lbl.pdf
  4. Brenner, D. M., & Lacy, B. E. (2021). Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options. American Journal of Gastroenterology, 116(8), 1587–1600. https://doi.org/10.14309/ajg.0000000000001266
  5. Broderick, E. D., Metheny, H., & Crosby, B. (2020). Anticholinergic Toxicity. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK534798/
  6. Cloyd, J. (2023, March 29). A Root Cause Medicine Guide to Ulcerative Colitis. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-guide-to-ulcerative-colitis
  7. Cloyd, J. (2023, April 14). A Functional Medicine Glaucoma Protocol. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-glaucoma-protocol
  8. Cloyd, J. (2023, October 9). Rhythms of the Heart: Demystifying Common Types of Heart Arrhythmia. Rupa Health. https://www.rupahealth.com/post/rhythms-of-the-heart-demystifying-common-types-of-heart-arrhythmia
  9. Cloyd, J. (2024, February 2). Navigating dietary management for IBS: A functional medicine perspective. Rupa Health. https://www.rupahealth.com/post/navigating-dietary-management-for-ibs-a-functional-medicine-perspective
  10. Cloyd, J. (2024, June 20). Understanding Heart Palpitations: Causes, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/understanding-heart-palpitations-causes-diagnosis-and-treatment
  11. Dicyclomine. GoodRx. https://www.goodrx.com/dicyclomine/what-is
  12. Dicyclomine. (2024). PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Dicyclomine#section=Biological-Half-Life
  13. DICYCLOMINE- dicyclomine hydrochloride tablet. (2021). DailyMed; National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a553bda-1e3d-4b80-913f-73dd54655033
  14. Diorio, B. (2022, November 3). Brain Fog, Muscles Weakness, and Constipation are Symptoms That This Neurotransmitter Could Be Low. Rupa Health. https://www.rupahealth.com/post/poor-short-term-memory-muscles-weakness-and-constipation-are-symptoms-of-low-levels-of-this-neurotransmitter
  15. Dodds, M., W. J., Haddou, M. B., & Day, J. E. L. (2023). The effect of gum chewing on xerostomia and salivary flow rate in elderly and medically compromised subjects: a systematic review and meta-analysis. BMC Oral Health, 23(1). https://doi.org/10.1186/s12903-023-03084-x
  16. Evans, A. (2024, September 19). 9 Dicyclomine Side Effects You Should Know About. GoodRx. https://www.goodrx.com/dicyclomine/dicyclomine-side-effects
  17. Glaucoma Medicines. (2021, July 19). National Eye Institute. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/glaucoma/glaucoma-medicines
  18. Greenan, S. (2021, November 18). How To Do A Low FODMAP Elimination Diet. Rupa Health. https://www.rupahealth.com/post/what-are-fodmaps
  19. Greenan, S. (2022, January 7). 5 lifestyle habits that increase your risk of GERD. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-gerd
  20. Hetterich, L., & Stengel, A. (2020). Psychotherapeutic Interventions in Irritable Bowel Syndrome. Frontiers in Psychiatry, 11. https://doi.org/10.3389/fpsyt.2020.00286
  21. Johannesson, E. (2015). Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects. World Journal of Gastroenterology, 21(2), 600. https://doi.org/10.3748/wjg.v21.i2.600
  22. Kalola, U. K., Patel, P., & Chowdhury, Y. S. (2024). Linaclotide. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/35201736/
  23. Khanna, R., MacDonald, J. K., & Levesque, B. G. (2013). Peppermint Oil for the Treatment of Irritable Bowel Syndrome. Journal of Clinical Gastroenterology, 48(6), 505–512. https://doi.org/10.1097/mcg.0b013e3182a88357
  24. Kresge, K. (2022, April 6). 9 Common Things That May Be Causing Your Constipation. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-treating-constipation
  25. Kresge, K. (2022, October 31). IBS vs IBD: Know the symptoms. Rupa Health. https://www.rupahealth.com/post/ibs-vs-ibd-know-the-symptoms
  26. Kresge, K. (2022, December 22). Functional Gastrointestinal Disorders: Diagnosis and Treatment. Rupa Health. https://www.rupahealth.com/post/what-are-functional-gastrointestinal-disorders-diagnosis-and-treatment
  27. Lacy, B. E., Pimentel, M., Brenner, D. M., et al. (2021). ACG Clinical guideline: Management of irritable bowel syndrome. American Journal of Gastroenterology, 116(1), 17–44. https://doi.org/10.14309/ajg.0000000000001036
  28. Lobello Pearson, S. (2022, June 24). What Are Anticholinergic Medications? GoodRx. https://www.goodrx.com/classes/anticholinergics/anticholinergic-drugs-medications
  29. Lotronex (alosetron hydrochloride) Information. (2018, November 3). U.S. Food & Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/lotronex-alosetron-hydrochloride-information
  30. LUBIPROSTONE - HIGHLIGHTS OF PRESCRIBING INFORMATION. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021908s015lbl.pdf
  31. Naji, A., & Gatling, J. W. (2020). Muscarinic Antagonists. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557541/
  32. Page, J. G., & Dirnberger, G. (1981). Treatment of the Irritable Bowel Syndrome with Bentyl® (Dicyclomine Hydrochloride). Journal of Clinical Gastroenterology, 3(2), 153–156. https://doi.org/10.1097/00004836-198106000-00009
  33. Ramnarine, M. (2024, August 2). Anticholinergic Toxicity. Medscape. https://emedicine.medscape.com/article/812644-overview#a8
  34. Reding, K. W., Cain, K. C., Jarrett, M. E., et al. (2013). Relationship between Patterns of Alcohol Consumption and Gastrointestinal Symptoms among Patients with Irritable Bowel Syndrome. The American Journal of Gastroenterology, 108(2), 270–276. https://doi.org/10.1038/ajg.2012.414
  35. Robertson, K. D., & Nagalli, S. (2021). Rifaximin. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK562329/
  36. Rodríguez-Ramallo, H., Báez-Gutiérrez, N., Prado-Mel, E., et al. (2021). Association between Anticholinergic Burden and Constipation: A Systematic Review. Healthcare, 9(5), 581. https://doi.org/10.3390/healthcare9050581
  37. VIBERZI - HIGHLIGHTS OF PRESCRIBING INFORMATION. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206940s003lbl.pdf
  38. Waldfogel, M. P. (2024, January 19). Beyond Dry January - How to Help Patients Reduce or Eliminate Alcohol Consumption. Rupa Health. https://www.rupahealth.com/post/beyond-dry-january---how-to-help-patients-reduce-or-eliminate-alcohol-consumption
  39. Weinberg, J. L. (2022, November 8). Drooping of the Eye and Double Vision Are the First Symptoms in More Than Half of People Who Develop This Autoimmune Disease. Rupa Health. https://www.rupahealth.com/post/myasthenia-gravis
  40. What Causes IBS? Key Factors and Triggers Explained. (2024, August 28). Rupa Health. https://www.rupahealth.com/post/what-causes-ibs-key-factors-and-triggers-explained
  41. What Triggers IBS Symptoms? Key Factors Explained. (2024, August 28). Rupa Health. https://www.rupahealth.com/post/what-triggers-ibs-symptoms-key-factors-explained
  42. Wilkins, T., Pepitone, C., Alex, B., et al. (2012). Diagnosis and Management of IBS in Adults. American Family Physician, 86(5), 419–426. https://www.aafp.org/pubs/afp/issues/2012/0901/p419.html
  43. Yoshimura, H. (2023, November 7). The remarkable power of exercise on our health: A comprehensive overview. Rupa Health. https://www.rupahealth.com/post/the-remarkable-power-of-exercise-on-our-health-a-comprehensive-overview
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.